Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

More moms insured thanks to Affordable Care Act

The Urban Institute released a study examining the effect the opening of the health insurance marketplaces had on the long-term rise in the percentage of uninsured mothers.

CMS may change Medicare Part B proposal after criticisms from Congress

Current plan calls for a five-year pilot program that would change the reimbursement calculation.

Florida doctor convicted of 162 counts of healthcare fraud

A federal jury has convicted Ona Colasante, MD, of 162 counts of health care fraud.

HHS awards $260M to build and renovate health centers

The money comes from the Community Health Center Fund, first established by the Affordable Care Act and extended by the passing of MACRA in 2015.

CMS delays star ratings for HealthCare.gov plans

CMS is further delaying the star rating system intended to help patients make decisions when they shop for insurance on HealthCare.gov, reports Modern Healthcare.

5 thoughts on navigating healthcare's future landscape

With more healthcare companies expanding and others combining to form technological powerhouses the healthcare landscape is drastically changing. The question that healthcare leaders ask now becomes “how do we navigate through this unknown territory?”

Executive moves: April

April was a busy month for healthcare executives with new CEOs, CMOs and COOs coming up for spring.

BCBS plans in several states won’t accept credit cards for insurance payments

Blue Cross Blue Shield has announced its plans in Illinois and several other states will no longer accept credit cards as a form of payment.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.